Company patents

Cellino Biotech, Inc.

Cellino Biotech, Inc.'s patent strategy is heavily concentrated in Bioreactors / Cell Culture Apparatus, representing 92.6% of its portfolio, despite a notable decline of -60.0% in 2025 and -25.0% so far in 2026. Surprisingly, the company has also shown significant activity in Image Processing (63.0% of portfolio) and Material & Chemical Analysis (63.0% of portfolio), though both categories have seen substantial declines in patenting activity, with Material & Chemical Analysis and Laboratory Apparatus both experiencing a -100.0% YoY drop so far in 2026.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

27 US filings (since 2023) · 9 categories · 6 themes

Automated Bioreactor Control

Systems and methods for automated monitoring and dynamic adjustment of environmental parameters (e.g., pH, temperature, oxygen, nutrients) and fluid handling within bioreactors to optimize cell/tissue growth or product synthesis.

Bioreactors / Cell Culture Apparatus
Who else files here? →
23since 2023
-40.0%YoY
Bioreactor & Cell Culture Scaffolds

Devices and systems designed for the cultivation of cells or tissues, often incorporating three-dimensional structures or controlled interfaces to mimic in-vivo environments for biological research or production.

Laboratory Apparatus
Who else files here? →
20since 2023
-62.5%YoY
Cell Therapy & Bioproduction Processes

Methods and apparatus specifically tailored for the expansion, differentiation, or genetic modification of cells for therapeutic applications (e.g., CAR T cells, progenitor cells) or for the production of specific biological products (e.g., cultured fat, RNA).

Bioreactors / Cell Culture Apparatus
Who else files here? →
9since 2023
0.0%YoY
3D Cell & Organoid Culture

Techniques and apparatus for cultivating cells in three-dimensional structures, including organoids, tissue models, and scaffolds, often involving microfluidics, specialized matrices, or mechanical stimulation to mimic in vivo conditions.

Bioreactors / Cell Culture Apparatus
Who else files here? →
2since 2023
new
Targeted Drug Formulation Delivery

Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.

Pharmaceutical Preparations
Who else files here? →
2since 2023
n/a
Advanced Drug Delivery Systems

Development of lipid-based nanoparticles, liposomes, or other molecular platforms to encapsulate and deliver therapeutic agents, particularly nucleic acids, to target tissues or improve pharmacokinetics.

Nanotechnology
Who else files here? →
2since 2023
n/a

Patents

Showing 1-10 of 35

Page 1 of 4